JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

First published online August 14, 2008, 10.2967/jnumed.108.052464
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in JNM
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Remy, H.
Right arrow Articles by Ricard, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Remy, H.
Right arrow Articles by Ricard, M.

131I Effective Half-Life and Dosimetry in Thyroid Cancer Patients

Hervé Remy1, Isabelle Borget2, Sophie Leboulleux1, Nadine Guilabert1, Frédéric Lavielle3, Jérome Garsi4, Claire Bournaud1, Séverine Gupta1, Martin Schlumberger1,5 and Marcel Ricard3

1 Department of Nuclear Medicine, Institut Gustave Roussy, Villejuif, France; 2 Department of Health Economics, Institut Gustave Roussy, Villejuif, France; 3 Department of Medical Physics, Institut Gustave Roussy, Villejuif, France; 4 INSERM U 605, Institut Gustave Roussy, Villejuif, France; and 5 University Paris-Sud, Bicêtre, France


Figure 1
View larger version (19K):
[in this window]
[in a new window]

  		FIGURE 1.  Cumulated urinary excretion activity: comparison between withdrawal patients (THW) and rhTSH patients.

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2008 by the Society of Nuclear Medicine.